L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's (BIOT:SW) last reported annual revenue was N/A.
L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's (BIOT:SW) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) is not profitable as of its last reported annual financials.
The net profit margin for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) from its laster reported year is N/A
The return on equity (ROE) for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) from its last reported annual financials is : N/A
The return on assets (ROA) for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) from its last reported annual financials is : N/A
The Debt to Equity ratio for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) from its last reported annual financials is : N/A
The dividend yield for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) from its laster reported year is 0.94%
L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF's(BIOT:SW) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BIOT:SW !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
